Industry Presentations
Delaying Progression of mHSPC
Presentations
Delaying Progression of mHSPC with New Treatment Options
Speakers: Neal D. Shore, MD, FACSEdwin M. Posadas, MD, FACP, KME. David Crawford, MD Duration: 60 minutes
Presented on: August 31, 2022
*This session is not eligible for AMA PRA Category 1 CreditsTM
Patient Considerations for a New Standard of Care for mHSPC
Speakers: Neal D. Shore, MD, FACSScott Sellinger, MD, FACS, President, Advanced Urology InstituteElisabeth Heath, MD FACP, Associate Center Director, Translational Sciences Duration: 60 minutes
Presented on: October 31, 2022
*This session is not eligible for AMA PRA Category 1 CreditsTM
The Evolution of the Modern Care Team with New mHSPC Treatment Options
Speakers: Neal D. Shore, MD, FACSMatthew R. Smith, MD, PhD, Professor of MedicineDavid Morris, MD, FACS, President, Co-Director Duration: 60 minutes
Presented on: February 23, 2023
*This session is not eligible for AMA PRA Category 1 CreditsTM
Speakers
Neal D. Shore, MD, FACS
Neal D. Shore, MD, FACS
Neal D. Shore, MD, FACS is the Medical Director for the Carolina Urologic Research Center. He practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina.
Dr. Shore has conducted more than 350 clinical trials, focusing mainly on GU Oncology, and serves on the Executive Boards of: Society of Urologic Oncology Board, Bladder Cancer Advocacy Network, and is Immediate Past President, Large Urology Group Practice Association. He is a founder for both: CUSP Clinical Trials Consortium, as well as for DASHKO, large urology practices data registries. He serves as the National Urology Research Director for 21st Century Oncology. He has served on the AUA Male Health Committee and the AUA Data Committee, the SITC Task Force for Prostate Cancer, the Bladder Cancer Advocacy Think Tank and the editorial boards of Reviews in Urology, Urology Times, Chemotherapy Advisor, OncLive, PLOS ONE(Academic Editor), Urology Practice, World Journal of Urology, and serves as Editor, Everyday Urology-Oncology. He has more than 175 peer reviewed publications and numerous book chapters; he performs peer review for Lancet Oncology, New England Journal of Medicine, European Urology, Journal Urology, Urology, BJUI, PCPD, and numerous other high impact scientific journals.
A graduate of Duke University and Duke University Medical School, Dr. Shore completed a 6-month clinical research fellowship in Pretoria, South Africa, and then completed his General Surgery/Urology training at New York Hospital Cornell Medical Center and at Memorial Sloan-Kettering Cancer Center in New York City. He is a Fellow of the American College of Surgeons.
Edwin M. Posadas, MD, FACP, KM
Edwin M. Posadas, MD, FACP, KM
E. David Crawford, MD
E. David Crawford, MD
Scott Sellinger, MD, FACS
Scott Sellinger, MD, FACS
President, Advanced Urology Institute
Scott Sellinger, MD, FACS, is president of the Advanced Urology Institute (AUI) in Tallahassee, Florida, chairs the Advanced Prostate Cancer (APC) Committee, and oversees seven APC clinics within AUI. In addition, he has served on the board of directors for the Large Urology Group Practice Association (LUGPA) for the past six years. Dr Sellinger has developed a special interest in risk management and prevention of medical errors and has lectured extensively on these subjects during the past several years. He is also interested in large group practice development and management.
Elisabeth Heath, MD FACP
Elisabeth Heath, MD FACP
Associate Center Director, Translational Sciences
Matthew R. Smith, MD, PhD
Matthew R. Smith, MD, PhD
Professor of Medicine
David Morris, MD, FACS
David Morris, MD, FACS
President, Co-Director
